Table 8.
Association Results of the Top SNP Associated With RHTN in INVEST‐GENES, ATP2B1 rs12817819, by Gender in INVEST‐GENES
| Gender | Minor Allele | Race | n | MAF | OR (95% CI) | P Value | Meta‐Analysis OR (95% CI) | Meta‐Analysis P Value |
|---|---|---|---|---|---|---|---|---|
| Males | A | EA | 501 | 0.124 | 1.70 (1.14 to 2.55) | 0.0093 | 1.77 (1.44 to 2.10) | 6.16E‐04 |
| Hispanic | 302 | 0.119 | 1.91 (1.08 to 3.40) | 0.0254 | ||||
| Females | A | EA | 403 | 0.137 | 1.41 (0.91 to 2.19) | 0.1226 | 1.56 (1.26 to 1.86) | 3.53E‐03 |
| Hispanic | 535 | 0.108 | 1.70 (1.13 to 2.57) | 0.0116 |
EA indicates European American; INVEST‐GENES, INternational VErapamil SR Trandolapril Study–GENEtic Substudy; MAF, minor allele frequency; n, number; odds ratio; RHTN, resistant hypertension; SNP, single‐nucleotide polymorphism.